PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 10 days 18 hours 42 minutes
Optimising the Treatment of mRCC From the Start: Evaluating the Impact of Evolving First-Line Strategies
Visit https://www.peervoice.com/KJG860 to view the entire programme with slides.
Teaming Up to Improve Outcomes in Immunology: The Importance of an Integrated Approach to Disease Control
Visit https://www.peervoice.com/SUW860 to view the entire programme with slides.
Elimination of Hepatitis C: Simple Changes for Comprehensive Results
Elimination of Hepatitis C: Simple Changes for Comprehensive Results
Beyond Positive and Negative HER2 Status: Defining HER2 Levels in Breast Cancer
Beyond Positive and Negative HER2 Status: Defining HER2 Levels in Breast Cancer
Targeting Remission in Auto-Inflammatory Diseases With Anti─IL-1β
Targeting Remission in Auto-Inflammatory Diseases With Anti─IL-1β
Imagining a World Without Hepatitis C Virus: A Call to Action
Imagining a World Without Hepatitis C Virus: A Call to Action
Aiming Higher in Advanced Cutaneous Squamous Cell Carcinoma: Experts Evaluate the Evidence for Immunotherapy
Visit https://www.peervoice.com/XAF860 to view the entire programme with slides.
Emerging ‘Tumour-Agnostic’ Oncology Treatment: The Role of the Pathologist in Identifying Neurotrophic Tyrosine Kinase Gene Fusions
Visit https://www.peervoice.com/VMX860 to view the entire programme with slides.
Merging Clinical Trial Results and Reality: The Real-World Implications of Androgen Receptor Antagonists for Non–Metastatic Castration-Resistant Prostate Cancer
Visit https://www.peervoice.com/VNN860 to view the entire programme with slides.
Should We Be Treating Ulcerative Colitis as a Progressive Disease?
Should We Be Treating Ulcerative Colitis as a Progressive Disease?